Literature DB >> 19908940

Colorectal carcinoma: Importance of colonic environment for anti-cancer response and systemic immunity.

Luca Vannucci1, Renata Stepankova, Valeria Grobarova, Hana Kozakova, Pavel Rossmann, Klara Klimesova, Veronika Benson, Petr Sima, Anna Fiserova, Helena Tlaskalova-Hogenova.   

Abstract

The intestinal environment is considered to play an important role both in colorectal tumor development and in the evolution and modulation of mucosal immunity. Studies in animals reared in germ-free (GF, without any intestinal microflora) versus conventional (CV, with regular microflora in bowel) conditions can aid in clarifying the influence of bacteria on carcinogenesis and anti-cancer immune responses in situ. The lower incidence of colon cancers and better immunological parameters in GF animals versus CV ones after chemically-induced carcinogenesis raises questions about specific characteristics of the immunological networks in each respective condition. Different levels of tolerance/regulatory mechanisms in the GF versus CV animals may influence the development of immune responses not only at the level of mucosal, but also at the systemic, immunity. We hypothesize that GF animals can better recognize and respond to evolving neoplasias in the bowel as a consequence of their less-tolerogenic immunity (i.e., due to their more limited exposure to antigens to become tolerated against at the intestinal level). In this paper, we review the role of bacteria in modulating gut environment and mucosal immunity, their importance in cancer development, and aspects of immune regulation (both at local and systemic level) that can be modified by bacterial microflora. Lastly, the use of GF animals in comparison with conventionally-raised animals is proposed as a suitable and potent model for understanding the inflammatory network and its effect on cancer immunity especially during colorectal cancer development.

Entities:  

Mesh:

Year:  2009        PMID: 19908940     DOI: 10.3109/15476910903334343

Source DB:  PubMed          Journal:  J Immunotoxicol        ISSN: 1547-691X            Impact factor:   3.000


  12 in total

Review 1.  The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases.

Authors:  Helena Tlaskalová-Hogenová; Renata Stěpánková; Hana Kozáková; Tomáš Hudcovic; Luca Vannucci; Ludmila Tučková; Pavel Rossmann; Tomáš Hrnčíř; Miloslav Kverka; Zuzana Zákostelská; Klára Klimešová; Jaroslava Přibylová; Jiřina Bártová; Daniel Sanchez; Petra Fundová; Dana Borovská; Dagmar Srůtková; Zdeněk Zídek; Martin Schwarzer; Pavel Drastich; David P Funda
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

2.  Plasma levels of resistin-like molecule beta in humans.

Authors:  Andrew P Neilson; Zora Djuric; Susan Land; Ikuko Kato
Journal:  Cancer Epidemiol       Date:  2010-11-19       Impact factor: 2.984

Review 3.  Gnotobiotic mouse model's contribution to understanding host-pathogen interactions.

Authors:  Klara Kubelkova; Milota Benuchova; Hana Kozakova; Marek Sinkora; Zuzana Krocova; Jaroslav Pejchal; Ales Macela
Journal:  Cell Mol Life Sci       Date:  2016-08-20       Impact factor: 9.261

Review 4.  Biochemical and molecular aspects of 1,2-dimethylhydrazine (DMH)-induced colon carcinogenesis: a review.

Authors:  Karthikkumar Venkatachalam; Ramachandran Vinayagam; Mariadoss Arokia Vijaya Anand; Nurulfiza Mat Isa; Rajasekar Ponnaiyan
Journal:  Toxicol Res (Camb)       Date:  2020-03-30       Impact factor: 3.524

5.  Perspectives on the treatment of colorectal carcinoma.

Authors:  Ren Zhao; Jing Li
Journal:  World J Gastrointest Oncol       Date:  2010-05-15

6.  Altered gut microbiota promotes colitis-associated cancer in IL-1 receptor-associated kinase M-deficient mice.

Authors:  Klara Klimesova; Miloslav Kverka; Zuzana Zakostelska; Tomas Hudcovic; Tomas Hrncir; Renata Stepankova; Pavel Rossmann; Jakub Ridl; Martin Kostovcik; Jakub Mrazek; Jan Kopecny; Koichi S Kobayashi; Helena Tlaskalova-Hogenova
Journal:  Inflamm Bowel Dis       Date:  2013-05       Impact factor: 5.325

7.  Blueberry husks and probiotics attenuate colorectal inflammation and oncogenesis, and liver injuries in rats exposed to cycling DSS-treatment.

Authors:  Asa Håkansson; Camilla Bränning; Göran Molin; Diya Adawi; Marie-Louise Hagslätt; Bengt Jeppsson; Margareta Nyman; Siv Ahrné
Journal:  PLoS One       Date:  2012-03-23       Impact factor: 3.240

Review 8.  Human Microbiome: When a Friend Becomes an Enemy.

Authors:  Magdalena Muszer; Magdalena Noszczyńska; Katarzyna Kasperkiewicz; Mikael Skurnik
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2015-02-15       Impact factor: 4.291

9.  Analysis of 12 variants in the development of gastric and colorectal cancers.

Authors:  Giovanna C Cavalcante; Marcos At Amador; André M Ribeiro Dos Santos; Darlen C Carvalho; Roberta B Andrade; Esdras Eb Pereira; Marianne R Fernandes; Danielle F Costa; Ney Pc Santos; Paulo P Assumpção; Ândrea Ribeiro Dos Santos; Sidney Santos
Journal:  World J Gastroenterol       Date:  2017-12-28       Impact factor: 5.742

Review 10.  Spontaneous and Induced Tumors in Germ-Free Animals: A General Review.

Authors:  Rajbardhan Mishra; Lenka Rajsiglová; Pavol Lukáč; Paolo Tenti; Peter Šima; Fabián Čaja; Luca Vannucci
Journal:  Medicina (Kaunas)       Date:  2021-03-11       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.